These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2436756

  • 1. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
    Stoter G, Sylvester R, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M.
    Cancer Res; 1987 May 15; 47(10):2714-8. PubMed ID: 2436756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec 15; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
    Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA.
    Br J Cancer; 1999 Jul 15; 80(9):1392-9. PubMed ID: 10424741
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
    Fossa SD, Paus E.
    Prog Clin Biol Res; 1985 Jul 15; 203():121. PubMed ID: 2421325
    [No Abstract] [Full Text] [Related]

  • 7. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ.
    Semin Oncol; 1998 Apr 15; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [Abstract] [Full Text] [Related]

  • 8. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD.
    Cancer; 1997 Jan 15; 79(2):345-55. PubMed ID: 9010108
    [Abstract] [Full Text] [Related]

  • 9. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K, Culine S, Kramar A, Amato RJ, Bouzy J, Chen I, Droz JP, Logothetis CJ.
    J Clin Oncol; 2004 Oct 01; 22(19):3868-76. PubMed ID: 15302906
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].
    Germa Lluch JR, Bastus Piulats R.
    Actas Urol Esp; 1987 Oct 01; 11(3):293-8. PubMed ID: 2444075
    [No Abstract] [Full Text] [Related]

  • 12. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK, Stephenson AJ, Gilligan T, Klein EA.
    Urol Clin North Am; 2007 May 01; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy of disseminated seminoma.
    Einhorn LH, Williams SD.
    Cancer Clin Trials; 1980 May 01; 3(4):307-13. PubMed ID: 6159120
    [Abstract] [Full Text] [Related]

  • 15. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
    Mikami K, Nakagawa S, Sugimoto K, Nomoto T, Urano S, Watanabe H, Iwamoto N, Yamazaki S, Hiratake Y, Maegawa M.
    Hinyokika Kiyo; 1997 Aug 01; 43(8):561-6. PubMed ID: 9310778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.
    Bosl GJ, Geller NL, Cirrincione C, Vogelzang NJ, Kennedy BJ, Whitmore WF, Vugrin D, Scher H, Nisselbaum J, Golbey RB.
    Cancer Res; 1983 Jul 01; 43(7):3403-7. PubMed ID: 6850645
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
    Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ.
    J Clin Oncol; 2004 Jun 15; 22(12):2395-403. PubMed ID: 15197201
    [Abstract] [Full Text] [Related]

  • 20. A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer.
    Stoter G, Sylvester R, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M.
    Prog Clin Biol Res; 1988 Jun 15; 269():381-93. PubMed ID: 2455909
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.